The estimated Net Worth of Biotech Inc. Portage is at least $8.06 Billion dollars as of 19 January 2018. Biotech Portage owns over 59,396 units of Biohaven Ltd stock worth over $1,946,526 and over the last 7 years Biotech sold BHVN stock worth over $8,053,062,081.
Biotech has made over 4 trades of the Biohaven Ltd stock since 2018, according to the Form 4 filled with the SEC. Most recently Biotech sold 59,396 units of BHVN stock worth $8,049,366,115 on 19 January 2018.
The largest trade Biotech's ever made was selling 84,881 units of Biohaven Ltd stock on 5 January 2018 worth over $2,551,523. On average, Biotech trades about 46,069 units every 4 days since 2018. As of 19 January 2018 Biotech still owns at least 54,494 units of Biohaven Ltd stock.
You can see the complete history of Biotech Portage stock trades at the bottom of the page.
Biotech's mailing address filed with the SEC is 47 Avenue Rd #200, Toronto, ON M5R 2G3, Canada.
Over the last 8 years, insiders at Biohaven Ltd have traded over $8,186,598,135 worth of Biohaven Ltd stock and bought 8,852,002 units worth $137,738,037 . The most active insiders traders include Robert J Hugin, John W Childs, and Declan Doogan. On average, Biohaven Ltd executives and independent directors trade stock every 14 days with the average trade being worth of $2,840,776. The most recent stock trade was executed by John W Childs on 18 July 2024, trading 28,400 units of BHVN stock currently worth $1,013,028.
Biohaven Ltd executives and other stock owners filed with the SEC include: